Commit To Buy Acadia Pharmaceuticals At $32, Earn 13.8% Using Options
July 22, 2015 at 11:32 AM EDT
Investors considering a purchase of Acadia Pharmaceuticals Inc (ACAD) stock, but tentative about paying the going market price of $49.37/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2017 put at the $32 strike, which has a bid at the time of this writing of $4.40..